Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing to launch Auvelity in Alzheimer’s disease ...

A clear overview of sleep disorders, their signs, risks, and treatments, with practical tips to improve sleep quality and ...

We just covered the 10 Best Stocks to Buy Right Now According to AI and Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) ...

Topline results from the phase 3 REVITALYZ study show sodium oxybate extended release improves daytime sleepiness in idiopathic hypersomnia.

You could risk a £1,000 fine if you don't tell them when you need to ...

Alkermes (ALKS) shares gained in the premarket on Tuesday after the company announced that its sleep disorder therapy Lumryz reached the primary goal in a late-stage trial for patients with idiopathic ...

In this article, we discuss the 10 Best Stocks to Buy Right Now According to AI. The US economy is navigating a complex and difficult environment defined by decelerating growth, persistent ...

— 26 Abstracts Accepted Demonstrate Alkermes’ Commitment to Advancing Understanding and Treatment of Narcolepsy and Idiopathic Hypersomnia — — Detailed Positive Results from Vibrance-2 Phase 2 Study ...

Alkermes ( (ALKS)) has shared an update. On May 12, 2026, Alkermes reported positive topline results from its phase 3 REVITALYZ trial of LUMRYZ in adults with idiopathic hypersomnia, showing ...

On a recent conference call, Axsome Therapeutics reported strong year-over-year growth across its business in the first ...

The most common cause of vertigo, benign paroxysmal positional vertigo, or BPPV, can be debilitating and often recur in ...

If your mind won't stop racing, these nine empathy-based strategies can help you quit overthinking and reconnect with peace, ...